arrow
Return

Integrating Incompatible Assay Data Sets with Deep Preference Learning

delete2021-12-29
delete2
delete
OA
AI
孙晓琳 cover
孙晓琳 (Xiaolin Sun)
R
Ryo Tamura
M
Masato Sumita
K
Kenichi Mori
K
Kei Terayama
K
Koji Tsuda *
DOI:10.1021/acsmedchemlett.1c00439delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
A large amount of bioactivity assay data is already accumulated in public databases, but the integration of these data sets for quantitative structure-activity relationship (QSAR) studies is not straightforward due to differences in experimental methods and settings. We present an efficient deep-learning-based approach called Deep Preference Data Integration (DPDI). For integrating outcome variables of different assay types, a surrogate variable is introduced, and a neural network is trained such that the total order induced by the surrogate variable is maximally consistent with given data sets. In a task of predicting efficacy of factor Xa inhibitors, DPDI successfully integrated 2959 molecules distributed in 129 assay data sets. In most of our experiments, data integration improved prediction accuracy strongly in interpolation and extrapolation tasks, indicating that DPDI is an effective tool for QSAR studies.
Keywords:
Data integration
Preference learning
Deep learning
Bioactivity data
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

ACS Medicinal Chemistry Letters cover
ACS Medicinal Chemistry Letters
IF:
4
Papers:
4.4K
Citations:
10.0K

Organization

U
University of Tokyo
Scholars:
7.1W
Papers: 6.5W
Citations: 2.2K
A
astellas pharmaceuticals
Scholars:
2.6K
Papers: 1.4K
Citations: 0
R
riken
Scholars:
2.2W
Papers: 1.9W
Citations: 24
researcher View more organizations